Home > Products > CD19 & CD47
> Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Miniantibody)
Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Miniantibody) (CAT#: MNAB-042)
Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Miniantibody) is a fusion protein of two scFv fragments combined with distinct specificity. One scFv of an anti-CD19 antibody variable domain is linked to another scFv of an anti-CD47 antibody variable domain by a flexible hinge region. This BsAb format has the decreased size and better penetration than conventional IgGs in the clinical diagnostics and potentially therapy. This BsAb can target CD19+ cells and block the CD47-SIRPα signal. It is designed for the research of B cell lymphoma; Follicular lymphoma; Burkitt lymphoma; Leukemia therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD19 x Anti-CD47 Bispecific Antibody (Miniantibody) (MNAB-042). Click the button below to contact us or submit your feedback about this product.